Mtb ATP synthase-IN-1 (compound 6ab) is a potent Mycobacterium tuberculosis ( Mtb ) ATP synthase inhibitor, with MIC of 0.452-0.499 μg/mL against Mtb . Mtb ATP synthase-IN-1 has good metabolic stability, low cytotoxicity (Vero IC 50 > 64 μg/mL), and acceptable oral bioavailability. Mtb ATP synthase-IN-1 can be used for researching anti-mycobacterium In Vivo Mtb ATP synthase-IN-1 (50 mg/kg for PO, 5 mg/kg for IV; single dosage) exhibits good metabolic stability and acceptable oral bioavailability . Pharmacokinetic Parameters of Mtb ATP synthase-IN-1 in male CD-1 mouse . PO (50 mg/kg) IV (5 mg/kg) C max (ng/mL) 1333 1241 T max (h) 0.83 T 1/2 (h) 0.51 0.33 AUC 0-t (ng/mL·h) 2197 1667 AUC 0-∞ (ng/mL·h) 2198 1672 MRT 0-∞ (ng/mL) 1.36 0.28 CL (mL/min/kg) 51.4 F (%) 13.1 MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male CD-1 mouse Dosage: 50 and 5 mg/kg Administration: 50 mg/kg for PO, 5 mg/kg for IV; single dosage (Pharmacokinetics Analysis) Result: Exhibited good metabolic stability and acceptable oral bioavailability. Form:Solid IC50& Target:MIC: 0.452-0.499 μg/mL ( Mtb )
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Mtb ATP synthase-IN-1
CAS number:2642394-38-3 molecular formula:C17H13N3O4
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | - | ||
| CAS number | 2642394-38-3 | molecular formula | C17H13N3O4 |
| molecular weight | 323.30 g/mol | Exact mass | ≥98% |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





